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We commend Zernig et al. (2003) for trying to incorpo-
rate incentive-sensitization concepts into traditional be-
havioral pharmacology. However, their present
formulation suffers from three crucial misunderstandings.
Zernig et al. (2003) said that we “propose that increased
drug consumption is not due to tolerance but to sensiti-
zation to the drug’s reinforcing effect or ... an increase in
drug ‘wanting’”. Then, they presented an alternative
explanation. It is difficult to defend a position one never
took in the first place, but that is the position we find
ourselves.
The initial error Zernig et al. (2003) made regarding
incentive-sensitization was to say that drug reinforcement
roughly corresponds with what we have called drug
“wanting”. “Wanting” is a short-hand term for the process
of incentive salience attribution, not reinforcement (Rob-
inson and Berridge 1993, 2000, 2003; Berridge and
Robinson 1998). To equate reinforcement with “wanting”
badly distorts the concept of incentive salience and
incentive-sensitization theory. We have said it before and
we say it again: drug reinforcement does NOT correspond
to drug “wanting”.
In our initial paper on this topic (Robinson and
Berridge 1993), we included a glossary of terms, includ-
ing reinforcement, incentive salience and “wanting”. That
glossary defined reinforcement in the standard Skinnerian
way, as “a purely behavioral and descriptive term for the
relationship between the occurrence of a stimulus and
changes in the subsequent probability of a behavior” (see
p. 281 for the full entry). By contrast, we have consis-
tently defined “wanting” in terms such as, “it is the
process of incentive salience attribution that transforms
the sensory features of ordinary stimuli or, more accu-
rately, the neural and psychological representations of
stimuli, so that they become especially salient stimuli,
stimuli that “grab the attention”, that become especially
attractive and wanted, thus eliciting approach and guiding
behavior to the goal. It is incentive salience that
determines the value of incentives” (Robinson and
Berridge 2000, p S105).
These are obviously very different concepts. We have
gone to considerable lengths to distinguish incentive
salience from reinforcement, and have pointed out
limitations of Skinnerian reinforcement, even arguing
that “behaviorist reinforcement should not be mistaken to
be an explanation of either drug-taking or addiction in
either a physiological or psychological sense” (Robinson
and Berridge 2000, p S93; Berridge and Robinson 2003).
Zernig et al. (2003) made their second error about
incentive-sensitization when they said that we claim
incentive-sensitization to be manifest by an upward shift
in a cocaine dose–response rate curve. It could be, but we
have never said this, because we do not believe an upward
shift (or a shift in any direction) in a cocaine dose–
response rate curve necessarily indicates sensitization to
anything. If anyone else has said it, we think they might
misunderstand incentive-sensitization theory.
The kinds of dose–response rate functions discussed
here are simply the wrong instrument to properly test
incentive-sensitization, because they do not specifically
measure changes in incentive processes. The rate of drug
self-administration is susceptible to influence by too
many other processes distinct from incentive salience,
such as S-R habit effects, tolerance effects, hedonic
effects, cognitive effects, aversive effects, and other
effects of drugs. Shifts in dose–response rate functions
could be due to changes in any of these processes, making
them ambiguous to interpret (Wyvell and Berridge 2000;
Berridge and Robinson 2003; Robinson and Berridge
2003).
To measure incentive salience separately from other
effects, it is necessary to use paradigms that more
specifically probe it alone, such as Pavlovian conditioned
incentive procedures (e.g., Cardinal 2002; see for discus-
sion Wyvell and Berridge 2000, 2001; Berridge and
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Robinson 2003; Robinson and Berridge 2003). Impor-
tantly for incentive-sensitization theory, Pavlovian con-
ditioned motivational responses have been shown to
sensitize (Cardinal 2002). Indeed, sensitization of Pavlo-
vian motivational processes might be responsible for the
facilitatory effects of past drug treatment on the acqui-
sition of drug self-administration behavior (Piazza et al.
1989; Horger et al. 1990), conditioned place preference
(Lett 1989) and progressive ratio responding (Mendrek et
al. 1998; Lorrain et al. 2000), even though those are not
specific tests for incentive motivation. As we recently
said (Robinson and Berridge 2003, p 41–42), “the
evidence for sensitization of drug reward pursuit ... is
compatible with the incentive-sensitization view of
addiction, but it is not conclusive, because it could be
alternatively explained by changes in a number of other
components of reward or learning (Wyvell and Berridge
2000; Cardinal et al. 2002).” “In order to test whether
sensitization can specifically enhance incentive salience
or “wanting” triggered by reward cues (S–S associations),
it is necessary to design experiments so as to exclude
alternative explanations.” We then go on to explain how.
Finally, Zernig et al. (2003) asked, ‘why do addicts
escalate their dose?’, and they answered that it is due to
tolerance to the rate-decreasing effects of cocaine
(including aversive effects). Although incentive-sensiti-
zation could conceivably lead to dose escalation, their
view actually sounds similar to an alternative view we
expressed long ago. We wrote a decade ago that addicts
may “increase dose to achieve the more intense (and more
desirable) subjective effects produced by larger doses.
They are able to do this only because tolerance develops
to the aversive ‘side effects’ of drugs. That is, addicts
increase their dose because they can, without the dire
negative effects experienced by naive users. Doses that
might be unpleasant, or even life-threatening, in inexpe-
rienced users, are ‘tolerated’ by experienced users
because of tolerance to many of the drug’s negative
effects, including effects on the autonomic nervous
system” (Robinson and Berridge 1993, p 275). This
sounds very similar to the “new” view advocated by
Zernig et al. (2003), and so we come full circle. Tolerance
to aversive effects did not exclude a role for incentive-
sensitization in addiction in 1993, and it does not exclude
incentive-sensitization now. These two concepts are not
mutually exclusive explanations for the same phenome-
non. They are explanations for different phenomena and
are quite mutually compatible.
We applaud efforts to incorporate incentive-sensitiza-
tion concepts into operant behavioral pharmacology, but
we close with a fervent wish for fewer errors in the future.
To paraphrase the great American poet, Robert Frost
(from “The Fear of Man”):
“May we in our brief bolt across the scene
Not be misunderstood in what we mean.”
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